Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type 1a (GSD Ia) patients, yet it is unclear how hypoglycemia links to plasma triglyceride (TG) levels. We analyzed whole-body TG metabolism in normoglycemic (fed) and hypoglycemic (fasted) hepatocyte-specific glucose-6-phosphatase deficient (L-G6pc-/- ) mice. De novo fatty acid synthesis contributed substantially to hepatic TG accumulation in normoglycemic L-G6pc-/- mice. In hypoglycemic conditions enhanced adipose tissue lipolysis was the main driver of liver steatosis, supported by elevated free fatty acid concentrations in GSD Ia mice and -patients. Plasma VLDL levels were increased in GSD Ia patients and in normoglycemic L-G6pc-/- mice, and ...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Perturbed glucose signalling in liver cells induces several metabolic responses that adversely affec...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
Perturbed glucose signalling in liver cells induces several metabolic responses that adversely affec...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Perturbed glucose signalling in liver cells induces several metabolic responses that adversely affec...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
Prevention of hypertriglyceridemia is one of the biomedical targets in Glycogen Storage Disease type...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
International audiencePrevention of hypertriglyceridemia is one of the biomedical targets in Glycoge...
Perturbed glucose signalling in liver cells induces several metabolic responses that adversely affec...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Glycogen storage disease type 1a (GSD Ia) is an inborn error of carbohydrate metabolism. Despite sev...
Perturbed glucose signalling in liver cells induces several metabolic responses that adversely affec...